Cargando…

Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials

Objective: Systematic comparison of the efficacy and safety of nebulized corticosteroids and systemic corticosteroids for treating acute exacerbation of chronic obstructive pulmonary disease reported by high-quality, real-world observational studies and randomized controlled trials. Methods: MEDLINE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Han-Shuo, Wang, Zhuo, Zhao, Li-Mei, Liu, Xiao-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581123/ https://www.ncbi.nlm.nih.gov/pubmed/36278148 http://dx.doi.org/10.3389/fphar.2022.966637

Ejemplares similares

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China
por: Zhang, Jing, et al.
Publicado: (2019)

Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
por: Woods, J Andrew, et al.
Publicado: (2014)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022)

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
por: Chen, Hong, et al.
Publicado: (2021)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
por: Singh, Sonal, et al.
Publicado: (2010)

Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?
por: Aldibbiat, Ali M, et al.
Publicado: (2020)

The effects of nebulized ketamine and intravenous magnesium sulfate on corticosteroid resistant asthma exacerbation; a randomized clinical trial
por: Farshadfar, Kimia, et al.
Publicado: (2021)

Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2021)

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
por: Brereton, Christopher J., et al.
Publicado: (2020)

Short-Term Versus Long-Term Systemic Corticosteroid Use in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients
por: Alshehri, Samah, et al.
Publicado: (2021)

The role of antenatal corticosteroids in twin pregnancy
por: Zhu, Jie, et al.
Publicado: (2023)

Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients
por: Tchoukaev, Anastasia, et al.
Publicado: (2018)

Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid
por: Yong, Su-Boon, et al.
Publicado: (2023)

Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids
por: Huang, Yi-Jen, et al.
Publicado: (2021)

Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use
por: Kimura, Yuya, et al.
Publicado: (2021)

Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021
por: Wang, Chengshuo, et al.
Publicado: (2021)

T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
por: Kaur, Manminder, et al.
Publicado: (2012)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Rui, et al.
Publicado: (2020)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Lower-dose corticosteroid therapy in severe immune thrombocytopenia during pregnancy: The comparable efficacy and lower incidence of maternal complications
por: Xu, Xue, et al.
Publicado: (2022)

Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care
por: Al-ani, Salwan, et al.
Publicado: (2015)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
por: Ferguson, Gary T, et al.
Publicado: (2020)

Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort
por: Galerneau, Louis Marie, et al.
Publicado: (2023)

A Pilot Study of Nebulized Heparin for Prevention of Ventilator Induced Lung Injury: Comparative Effects with an Inhaled Corticosteroid
por: Ghiasi, Farzin, et al.
Publicado: (2017)

The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study
por: Yang, Jia-Wei, et al.
Publicado: (2021)

Pulmonary Diseases and Corticosteroids
por: Sethi, G.R., et al.
Publicado: (2008)

Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis
por: Chen, Yahong, et al.
Publicado: (2020)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Anan, Keisuke, et al.
Publicado: (2022)

Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study
por: Rollema, Corine, et al.
Publicado: (2019)

Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
por: Marghli, Soudani, et al.
Publicado: (2022)

Do Corticosteroids Still Have a Place in the Treatment of Chronic Pain?
por: Knezevic, Nebojsa Nick, et al.
Publicado: (2018)

Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review
por: Björnsson, Einar S., et al.
Publicado: (2022)

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources
por: Alhaider, S.A., et al.
Publicado: (2014)

Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis
por: Soe, Kay Khine, et al.
Publicado: (2023)

Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Cheng, Wenwen, et al.
Publicado: (2020)

Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis–Manifested Severe Disease
por: Cheng, Bin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvi9davi2rbnpsg986up99o6t3